Medtech firms’ C-suites have remained dynamic throughout 2026, as companies name new executives, pull talent from competitors and revamp their organizational structures.

New CEOs have been appointed at Hologic, STAAR Surgical and Danaher, among the companies hiring. Meanwhile, GE HealthCare, Baxter and Depuy Synthes, Johnson & Johnson’s orthopedics business, have all brought in new CFOs.

Other executive changes have been made over the past nine months.

In the latest moves, Zimmer Biomet restructured its Americas leadership team, resulting in the promotion of three people and the loss of one executive. Zimmer said the restructuring was meant to support its ongoing commercial transformation.

Meanwhile, Dexcom added to the responsibilities of CFO Jereme Sylvain, promoting him to chief operating officer alongside his financial duties; STAAR Surgical hired former CEO David Bailey to lead its commercial team; and Cleveland Diagnostics appointed Valerie Dixon as its CFO.

There’s been plenty of personnel news to watch this year. Check out MedTech Dive’s roundup of coverage for the industry’s key executive moves: